Oral Proteins and Peptides Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
口服蛋白质和肽是一类重要的药物,通过口服途径给药来治疗疾病,包括激素、胃和胃肠道疾病代谢紊乱。口服蛋白质和肽具有改善人类健康的巨大潜力,并在多种疾病的治疗中得到应用。口服蛋白质和肽用于治疗许多慢性疾病,糖尿病就是其中之一。
市场动态
口服蛋白质和肽市场正在加强制药公司之间的药物开发合作,正在推动市场增长。此外,它们还用于治疗许多恢复市场增长的慢性疾病。然而,高昂的成本与药物开发相关,限制了市场。鉴于新兴经济体的购买力有所增加,这是市场增长的机会。此外,制药公司开展的研发活动在预测期内增加了市场需求。
市场范围
《2031 年口服蛋白质和肽市场分析》是对制药行业的专业深入研究,特别关注全球市场趋势分析。该报告旨在提供口服蛋白质和肽市场的概述,并按药物类型、应用和地理位置进行详细的市场细分。预计口服蛋白质和肽市场在预测期内将出现高速增长。该报告提供了口服蛋白质和肽市场领先企业的市场状况的关键统计数据,并提供了市场的主要趋势和机会。
市场细分
口服蛋白质和肽市场根据药物类型和应用进行细分。根据药物类型,市场分为奥曲肽、利那洛肽、胰岛素、普卡那肽和降钙素。根据应用,市场分为荷尔蒙失调、胃病和胃病。消化系统疾病、糖尿病和骨骼疾病。
报告提供了行业的详细概述包括定性和定量信息。它提供了基于各个细分市场的口服蛋白质和肽市场的概述和预测。它还提供了 2021 年至 2031 年五个主要地区的市场规模和预测估计,即:北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 以及南美和非洲中美洲。每个地区的口服蛋白质和肽市场随后按各自的国家和细分市场进行细分。该报告涵盖了对全球18个国家以及该地区当前趋势和机遇的分析和预测。
该报告从需求和供应方面分析了影响口服蛋白质和肽市场的因素,并进一步评估了预测期内影响市场的市场动态,即驱动因素、限制因素、机会和未来趋势。该报告还为所有五个地区提供了详尽的 PEST 分析,即:北美、欧洲、亚太地区、中东和非洲以及南美洲和南美洲中美洲在评估影响这些地区口服蛋白质和肽市场的政治、经济、社会和技术因素后。
市场参与者
该报告涵盖了口服蛋白质和肽市场作为有机和无机增长策略的关键发展。许多公司都专注于有机增长战略,例如产品发布、产品批准以及专利和活动等其他战略。市场上见证的无机增长战略是收购、合作伙伴关系和合作伙伴关系。合作。这些活动为市场参与者扩大业务和客户群铺平了道路。随着全球市场对口服蛋白质和肽市场需求的不断增长,预计口服蛋白质和肽市场的市场参与者在未来将拥有利润丰厚的增长机会。下面提到的是从事口服蛋白质和肽市场的几家公司的名单。
该报告还包括口服蛋白质和肽市场主要公司的概况及其 SWOT 分析和市场策略。此外,该报告重点关注行业领先企业,提供公司简介、提供的组件和服务、过去三年的财务信息、过去五年的主要发展等信息。
- • Allergan Plc.• 阿斯利康 PLC• Biocon Limited • Chiasma Inc.• Generex Biotechnology Corp.• 诺和诺德 A/S• Oramed Pharmaceuticals Inc.•< span style="font-size: 10pt; font-family: verdana,geneva, sans-serif;">Proxima Concepts Limited(Diabetology Ltd.)• Synergy Pharmaceuticals Inc.• Tarsa Therapeutics Inc.
Insight Partner 的专业研究和分析团队由经验丰富的专业人士组成,拥有先进的统计专业知识,并在现有研究中提供各种定制选项。
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. Allergan Plc.
2. AstraZeneca PLC
3. Biocon Limited
4. Chiasma Inc.
5. Generex Biotechnology Corp.
6. Novo Nordisk A/S
7. Oramed Pharmaceuticals Inc.
8. Proxima Concepts Limited (Diabetology Ltd.)
9. Synergy Pharmaceuticals Inc.
10. Tarsa Therapeutics Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.